Ligand validation:3RY6

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3RY6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RY6_NAG_C_206	17%	70%	0.284	0.863	0.53	0.63	-	-	0	0	100%	1
3RY4_NAG_A_200	32%	70%	0.14	0.813	0.56	0.61	-	-	0	0	100%	1
3D5O_NAG_B_208	27%	66%	0.138	0.781	0.63	0.67	-	-	0	0	100%	1
9MCX_NAG_C_201	11%	76%	0.165	0.675	0.4	0.55	-	-	0	0	100%	1
9MCY_NAG_F_201	9%	62%	0.142	0.634	0.68	0.78	1	-	0	0	100%	1
9N5P_NAG_C_201	7%	23%	0.137	0.594	0.73	2.4	-	2	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.